Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Wittig

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Colorectal Disease|January 18, 2006
Critical comment: analyzing the effect of novel therapies on cytokine expression in inflammatory bowel disease: do cytokine levels reflect clinical response?B M Wittig, M Zeitz
Deutsche Medizinische Wochenschrift (1946)|July 14, 2001
[Cytokine and anti-cytokine therapy in chronic inflammatory bowel diseases]B M Wittig, M Zeitz
International Journal of Colorectal Disease|April 4, 2003
The gut as an organ of immunologyB M Wittig, M Zeitz
Zeitschrift Fur Gastroenterologie|October 14, 2000
Modulation of gastrointestinal inflammation by chimeric proteins in experimental modelsA Stallmach, B M Wittig, M Zeitz
Der Internist|March 29, 2001
[Modulation of cytokines in chronic inflammatory bowel diseases]B M Wittig, R Duchmann, A Stallmach, et al.
Deutsche Medizinische Wochenschrift (1946)|September 16, 2004
[Inflammatory bowel diseases]H Scherübl, B M Wittig, J C Hoffmann, et al.
The Journal of Experimental Medicine|June 22, 2000
Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7)B M Wittig, B Johansson, M Zöller, et al.
Alimentary Pharmacology & Therapeutics|July 18, 2006
Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's diseaseC Schmidt, B M Wittig, C Moser, et al.
Gut|February 14, 2003
Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel diseaseA Stallmach, B M Wittig, C Moser, et al.
Experimental and Molecular Pathology|December 6, 2001
Decreased CD44v6 expression in lamina propria lymphocytes of patients with inflammatory bowel diseaseK Pfister, B M Wittig, I Mueller-Molaian, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Colorectal Disease|January 18, 2006
Critical comment: analyzing the effect of novel therapies on cytokine expression in inflammatory bowel disease: do cytokine levels reflect clinical response?B M Wittig, M Zeitz
Deutsche Medizinische Wochenschrift (1946)|July 14, 2001
[Cytokine and anti-cytokine therapy in chronic inflammatory bowel diseases]B M Wittig, M Zeitz
International Journal of Colorectal Disease|April 4, 2003
The gut as an organ of immunologyB M Wittig, M Zeitz
Zeitschrift Fur Gastroenterologie|October 14, 2000
Modulation of gastrointestinal inflammation by chimeric proteins in experimental modelsA Stallmach, B M Wittig, M Zeitz
Der Internist|March 29, 2001
[Modulation of cytokines in chronic inflammatory bowel diseases]B M Wittig, R Duchmann, A Stallmach, et al.
Deutsche Medizinische Wochenschrift (1946)|September 16, 2004
[Inflammatory bowel diseases]H Scherübl, B M Wittig, J C Hoffmann, et al.
The Journal of Experimental Medicine|June 22, 2000
Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7)B M Wittig, B Johansson, M Zöller, et al.
Alimentary Pharmacology & Therapeutics|July 18, 2006
Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's diseaseC Schmidt, B M Wittig, C Moser, et al.
Gut|February 14, 2003
Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel diseaseA Stallmach, B M Wittig, C Moser, et al.
Experimental and Molecular Pathology|December 6, 2001
Decreased CD44v6 expression in lamina propria lymphocytes of patients with inflammatory bowel diseaseK Pfister, B M Wittig, I Mueller-Molaian, et al.
Pageof 4